AgingResearch.NewsJoin free

Reducing CD150HIGH hematopoietic stem cells

Reducing CD150HIGH hematopoietic stem cells has been studied in 1 paper since 2025: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Jan 2, 2025: “Reducing functionally defective old HSCs alleviates aging-related phenotypes in old recipient mice”.

Intervention

1 paper studies it1 findingUpdated

See all 1

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

  • 1 lab in 1 country
  • Funder: Howard Hughes Medical Institute
  • Animals1

What did studies of Reducing CD150HIGH hematopoietic stem cells find?

1

Studies of Reducing CD150HIGH hematopoietic stem cells measured 1 outcome; the most studied are aging phenotypes (1 study).

Aging phenotypes

downin mice1

1 study

  1. Reducing CD150HIGH hematopoietic stem cells decrease aging phenotypes in mice.

    “reducing the dysfunctional CD150high HSCs can alleviate aging phenotypes in old recipient mice”

    Animals

    Reducing functionally defective old HSCs alleviates aging-related phenotypes in old recipient mice

    Cell research

Latest

Related